Lei Gong
-
- MicroRNA in disease regulation 4
- Cancer, Hypoxia, and Metabolism 3
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
-
- Pituitary Gland Disorders and Treatments 8
-
- Glioma Diagnosis and Treatment 4
-
- Pancreatic function and diabetes 3
-
- Cardiovascular Disease and Adiposity 2
-
- Single-cell and spatial transcriptomics 2
- Co-authors
- Yan ZhangJilong QinBing ZhangWei‐Qiang GaoLin ZhongQianfei ZhangYazhuo ZhangMingxiang Zhang
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Lei Gong
36 papers receiving 675 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 159
- Immunology 165
- Endocrinology, Diabetes and Metabolism 118
- Oncology 159
- Geriatrics and Gerontology 17
Countries citing papers authored by Lei Gong
This map shows the geographic impact of Lei Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Gong more than expected).
Fields of papers citing papers by Lei Gong
This network shows the impact of papers produced by Lei Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Gong. The network helps show where Lei Gong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lei Gong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 15 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 3 | |
| 6 | 2020 | 7 | |
| 7 | 2019 | 9 | |
| 8 | 2019 | 27 | |
| 9 | 2018 | 42 | |
| 10 | 2016 | 24 | |
| 11 | 2016 | 7 | |
| 12 | 2015 | 119 | |
| 13 | 2015 | 12 | |
| 14 | 2015 | 32 | |
| 15 | 2014 | 20 | |
| 16 | 2013 | 2 | |
| 17 | 2013 | 67 | |
| 18 | 2012 | 23 | |
| 19 | 2011 | 26 | |
| 20 | 2008 | 44 |
About Lei Gong
Lei Gong is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Genetics, having authored 38 papers that have together received 679 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (8 papers), Glioma Diagnosis and Treatment (4 papers), MicroRNA in disease regulation (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Pancreatic function and diabetes (3 papers), Cardiovascular Disease and Adiposity (2 papers) and Single-cell and spatial transcriptomics (2 papers). The work is most often cited by research in Cancer Research (159 citations), Immunology (165 citations) and Endocrinology, Diabetes and Metabolism (118 citations). Lei Gong has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Yan Zhang, Jilong Qin, Bing Zhang, Wei‐Qiang Gao, Lin Zhong, Qianfei Zhang, Yazhuo Zhang, Mingxiang Zhang, Li Chen and Xinguo Hou. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.